Variant report
Variant | nsv887706 |
---|---|
Chromosome Location | chr7:14143900-14171253 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:14167244..14169485-chr7:14169676..14171320,2 | K562 | blood: | |
2 | chr7:14167244..14169485-chr7:14169676..14171320,2 | K562 | blood: | |
3 | chr7:14140015..14142063-chr7:14149644..14151263,2 | K562 | blood: | |
4 | chr7:14137681..14139670-chr7:14144330..14146165,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555293678 | chr7:14144430-14144431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs193079359 | chr7:14144442-14144443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76630415 | chr7:14144445-14144446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531675004 | chr7:14144482-14144483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541885986 | chr7:14144527-14144528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76422008 | chr7:14144558-14144559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184934847 | chr7:14144561-14144562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543326606 | chr7:14144576-14144577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563213407 | chr7:14144577-14144578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs80161758 | chr7:14144597-14144598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140161384 | chr7:14144598-14144599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533285919 | chr7:14144599-14144600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549496252 | chr7:14144604-14144605 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77840636 | chr7:14144605-14144606 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535468553 | chr7:14144608-14144609 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555457605 | chr7:14144614-14144615 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12533882 | chr7:14144663-14144664 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs534384493 | chr7:14144666-14144667 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12531493 | chr7:14144675-14144676 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs577444566 | chr7:14144696-14144697 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188663179 | chr7:14144697-14144698 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12539162 | chr7:14144728-14144729 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs143904580 | chr7:14144757-14144758 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369065291 | chr7:14144758-14144759 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs117287364 | chr7:14144815-14144816 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372101768 | chr7:14144871-14144872 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572245249 | chr7:14144875-14144876 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535115951 | chr7:14144888-14144889 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs17167865 | chr7:14144899-14144900 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs542659068 | chr7:14144912-14144913 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181082235 | chr7:14144913-14144914 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs367634889 | chr7:14144923-14144924 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73681620 | chr7:14144929-14144930 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs148622551 | chr7:14144975-14144976 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79563391 | chr7:14145012-14145013 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528855571 | chr7:14145040-14145041 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549041950 | chr7:14145067-14145068 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565779234 | chr7:14145078-14145079 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375837263 | chr7:14145089-14145090 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185346223 | chr7:14145094-14145095 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142107350 | chr7:14145134-14145135 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs370226195 | chr7:14145148-14145149 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188145195 | chr7:14145156-14145157 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377285709 | chr7:14145162-14145163 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559661477 | chr7:14145218-14145219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576337269 | chr7:14145225-14145226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs535445938 | chr7:14145232-14145233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76684051 | chr7:14145242-14145243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552024606 | chr7:14145274-14145275 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571588776 | chr7:14145275-14145276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Colorectal cancer | 21645411 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:14144400-14145200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr7:14144400-14145600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr7:14144600-14145000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr7:14144600-14145200 | Active TSS | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr7:14144600-14145200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr7:14144600-14145400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr7:14144600-14146400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr7:14144800-14145200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr7:14145200-14152600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr7:14145800-14146200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr7:14156000-14156600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr7:14156200-14156600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr7:14162400-14166200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
14 | chr7:14162800-14166000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr7:14163600-14165200 | Enhancers | Fetal Brain Male | brain |
16 | chr7:14164400-14164600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr7:14164400-14164800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr7:14164600-14165400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr7:14164600-14165800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
20 | chr7:14165200-14166000 | Enhancers | Gastric | stomach |
21 | chr7:14165400-14166000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |